Ophthalmic Clinical Trials Market thrives on AI-enabled patient screening
The global ophthalmic clinical trials market was valued at USD 1.5 billion in 2022, and it is expected to reach USD 2.5 billion by 2030. This growth reflects a compound annual growth rate (CAGR) of 6.6% between 2023 and 2030 North America set the pace in 2022, commanding a dominant revenue share of 44.1%. Meanwhile, the Asia Pacific region is projected to exhibit the fastest...
0 មតិយោបល់ 0 ភាគហ៊ុន 6 ទិដ្ឋភាព 0 ពិនិត្យ